| 2007-07 | 1-furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP | 최한곤 |
| 2017-12 | 2-Hydroxyoleic acid-inserted liposomes as a multifunctional carrier of anticancer drugs | 최한곤 |
| 2008-11 | Adaptive response to GSH depletion and resistance to L-buthionine-(S,R)-sulfoximine: involvement of Nrf2 activation | 최한곤 |
| 2016-07 | An albumin nanocomplex-based endosomal pH-activatable on/off probe system | 최한곤 |
| 2017-07 | Albumin nanoparticles with synergistic antitumor efficacy against metastatic lung cancers | 최한곤 |
| 2007-02 | Alpha-tocopheryl succinate sensitizes human colon cancer cells to exisulind-induced apoptosis | 최한곤 |
| 2017-03 | Analysis and optimization of drug solubility to improve pharmacokinetics | 최한곤 |
| 2009-06 | Analysis of enantiomers of sibutramine and its metabolites in rat plasma by liquid chromatography-mass spectrometry using a chiral stationary-phase column | 최한곤 |
| 2009-05 | The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling | 최한곤 |
| 2009-03 | The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling | 최한곤 |
| 2009-10 | Anti-inflammatory action of mollugin and its synthetic derivatives in HT-29 human colonic epithelial cells is mediated through inhibition of NF-kappa B activation | 최한곤 |
| 2018-07 | Beta-carotene-bound albumin nanoparticles modified with chlorin e6 for breast tumor ablation based on photodynamic therapy | 최한곤 |
| 2007-03 | Biodistribution and tissue expression kinetics of plasmid DNA complexed with polyethylenimines of different molecular weight and structure | 최한곤 |
| 2015-09 | Biomimetic DNA nanoballs for oligonucleotide delivery | 최한곤 |
| 2009-02 | Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides | 최한곤 |
| 2016-07 | Cationic drug-based self-assembled polyelectrolyte complex micelles: Physicochemical, pharmacokinetic, and anticancer activity analysis | 최한곤 |
| 2017-03 | Cefdinir Solid Dispersion Composed of Hydrophilic Polymers with Enhanced Solubility, Dissolution, and Bioavailability in Rats | 최한곤 |
| 2017-12 | Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods | 최한곤 |
| 2008-03 | Chloroquine-induced nitric oxide increase and cell death is dependent on cellular GSH depletion in A172 human glioblastoma cells | 최한곤 |
| 2015-07 | Clopidogrel Napadisilate Monohydrate Loaded Surface-Modified Solid Dispersion: Physicochemical Characterization and in Vivo Evaluation | 최한곤 |
| 2008-11 | Clotrimazole Ameliorates Intestinal Inflammation and Abnormal Angiogenesis by Inhibiting Interleukin-8 Expression through a Nuclear Factor-kappa B-Dependent Manner | 최한곤 |
| 2018-08 | Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy | 최한곤 |
| 2016-10 | Combined phototherapy in anti-cancer treatment: therapeutics design and perspectives | 최한곤 |
| 2015-10 | Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe | 최한곤 |
| 2018-01 | Comparison of a revaprazan-loaded solid dispersion, solid SNEDDS and inclusion compound: Physicochemical characterisation and pharmacokinetics | 최한곤 |
| 2016-07 | Comparison of solvent-wetted and kneaded L-sulpiride-loaded solid dispersions: Powder characterization and in vivo evaluation | 최한곤 |
| 2017-03 | Comparison of three different types of cilostazol-loaded solid dispersion: Physicochemical characterization and pharmacokinetics in rats | 최한곤 |
| 2017-08 | A conjugation of stearic acid to apotransferrin, fattigation-platform, as a core to form self-assembled nanoparticles: Encapsulation of a hydrophobic paclitaxel and receptor-driven cancer targeting | 최한곤 |
| 2018-08 | Cyclic RGD-conjugated Pluronic® blending system for active, targeted drug delivery | 최한곤 |
| 2018-01 | Degradation kinetics study of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) by a validated stability-indicating RP-HPLC method | 최한곤 |
